Targeting NANOG and FAK via Cx26-derived Cell-penetrating Peptides in Triple-negative Breast Cancer

Erin E. Mulkearns-Hubert(Cleveland Clinic), Ofer Reizes(Cleveland Clinic)
Molecular Cancer Therapeutics
September 13, 2023
Cited by 11


Related Papers